144 ·Filed Jul 9, 2026

RCUS

Arcus Biosciences, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed2mo ago SEC0001958244-26-000445
Actionable Insight • Neutral

The sale is pre-scheduled under a 10b5-1 plan, so no opportunistic signal. Monitor future insider activity for any acceleration of sales outside the plan.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
RCUS ▼ -1.04% at T+20d
NEUTRAL call ✗ call lost -1.04% · α vs SPY -3.46% · entry $28.92 → $28.62
Next anchor: T+60d due 7h ago
Latest observation: T+58 -16.66% FF3 residual α
Entry anchored
Jul 9, 03:59 PM ET
via exchange tick
T+1d
-2.94%
call -2.94% · α -2.17%
$28.07
settled 3mo ago
T+5d
-7.88%
call -7.88% · α -7.32%
$26.64
settled 3mo ago
T+20d
-1.04%
call -1.04% · α -3.46%
$28.62
settled 8w ago
T+60d
—
call — · α —
—
due 7h ago

Price Chart

Loading chart...

Executive Summary

Officer Juan Jaen filed Form 144 to sell 25,000 shares (approx. $749,000) under a 10b5-1 plan dated 02/27/2026. The trust associated with Jaen has been selling shares in June/July 2026. The sale is small relative to market cap and pre-planned, reducing informational content.

Key Facts

  • Officer Juan Jaen intends to sell 25,000 shares of Class A Common Stock (~$749,000).
  • Sale is under a Rule 10b5-1 trading plan adopted on 02/27/2026.
  • The Juan Carlos Jaen and Anita Galeana 2000 Trust has been selling shares since June 22, 2026 (cumulative ~75,000 shares).
  • Total shares outstanding: ~125.8 million; sale represents <0.02% of shares.

Financial Impact

Proposed sale of $749,000 in shares by officer under pre-existing 10b5-1 plan; negligible dilution.

dilution

Risk Factors

  • Insider selling could increase if the 10b5-1 plan is expanded, but current plan is routine.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (RCUS) — Batch item 10001958244-26-000445
Document: 0001958244-26-000445-index.html0001958244-26-000445
Document: 0001958244-26-000445.txt0001958244-26-000445
144 Filing (RCUS) — Batch item 40001958244-26-000445
Document: 0001958244-26-000445-index.html0001958244-26-000445
Document: 0001958244-26-000445.txt0001958244-26-000445
5 reports for RCUS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RCUS — sortable, filterable
TypeNow
Jul 9, 2026
12w ago
144
NEUTRAL ★ 3/10
$28.92 $28.62▼ −1.04%▼ −3.46%$24.20 (−16.32%)
Apr 21, 2026
23w ago
DEFA14A
NEUTRAL ★ 2/10
$26.62 $22.75▼ −14.54%▼ −17.70%$24.20 (−9.09%)
Apr 20, 2026
23w ago
8-K
BEARISH ★ 8/10
$22.74 $23.40▼ −2.90%▲ +1.30%$24.20 (−6.42%)
Apr 8, 2026
25w ago
144
NEUTRAL ★ 3/10
$23.28 $26.00▲ +11.68%▲ +4.12%$24.20 (+3.95%)
Feb 25, 2026
31w ago
8-K
MIXED ★ 6/10
$20.27 $21.46▲ +5.87%▲ +11.11%$24.20 (+19.39%)
Showing 5 of 5

US Market Status

Market Open — Closes in 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access